Education
About Us
Working with TipRanks
Follow Us
Hisamitsu Pharmaceutical Co (JP:4530)
OTHER OTC:4530
4530 Stock Chart & Stats
¥4020.00
-¥16.00(-0.39%)
At close: 4:00 PM EST
¥4020.00
-¥16.00(-0.39%)
Day’s Range― - ―
52-Week Range¥3,783.00 - ¥6,695.00
Previous CloseN/A
Volume86.40K
Average Volume (3M)139.59K
Market Cap
¥469.95B
Enterprise Value¥198.51B
Total Cash (Recent Filing)¥118.13B
Total Debt (Recent Filing)¥2.65B
Price to Earnings (P/E)23.3
Beta0.39
Next Earnings
Apr 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.43%
Share Statistics
EPS (TTM)97.00
Shares Outstanding75,164,894
10 Day Avg. Volume146,500
30 Day Avg. Volume139,593
Financial Highlights & Ratios
PEG Ratio0.23
Price to Book (P/B)1.12
Price to Sales (P/S)1.99
P/FCF Ratio62.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hisamitsu Pharmaceutical Co News
4530 FAQ
What was Hisamitsu Pharmaceutical Co’s price range in the past 12 months?
Hisamitsu Pharmaceutical Co lowest stock price was ¥3783.00 and its highest was ¥6695.00 in the past 12 months.
What is Hisamitsu Pharmaceutical Co’s market cap?
Hisamitsu Pharmaceutical Co’s market cap is ¥469.95B.
When is Hisamitsu Pharmaceutical Co’s upcoming earnings report date?
Hisamitsu Pharmaceutical Co’s upcoming earnings report date is Apr 09, 2026 which is in 87 days.
How were Hisamitsu Pharmaceutical Co’s earnings last quarter?
Hisamitsu Pharmaceutical Co released its earnings results on Jan 08, 2026. The company reported ¥97 earnings per share for the quarter, missing the consensus estimate of ¥137.1 by -¥40.1.
Is Hisamitsu Pharmaceutical Co overvalued?
According to Wall Street analysts Hisamitsu Pharmaceutical Co’s price is currently Overvalued.
Does Hisamitsu Pharmaceutical Co pay dividends?
Hisamitsu Pharmaceutical Co pays a Notavailable dividend of ¥60 which represents an annual dividend yield of 2.43%. See more information on Hisamitsu Pharmaceutical Co dividends here
What is Hisamitsu Pharmaceutical Co’s EPS estimate?
Hisamitsu Pharmaceutical Co’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hisamitsu Pharmaceutical Co have?
Hisamitsu Pharmaceutical Co has 75,164,894 shares outstanding.
What happened to Hisamitsu Pharmaceutical Co’s price movement after its last earnings report?
Hisamitsu Pharmaceutical Co reported an EPS of ¥97 in its last earnings report, missing expectations of ¥137.1. Following the earnings report the stock price went up 3.871%.
Which hedge fund is a major shareholder of Hisamitsu Pharmaceutical Co?
Currently, no hedge funds are holding shares in JP:4530
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Inc. is a Japan-based company primarily engaged in the research, development, manufacturing, and marketing of pharmaceutical products, with a strong focus on transdermal drug delivery systems. The company operates in various sectors, including prescription pharmaceuticals, over-the-counter (OTC) products, and medical devices. Core products include analgesics, anti-inflammatory medications, and treatments for various medical conditions, leveraging their expertise in patch technology and innovative drug formulations.
Technical Analysis
Sumitomo Dainippon Pharma Co
―
―
Tsumura & Co
―
Nippon Shinyaku Co., Ltd.
―
SAWAI GROUP HOLDINGS Co., Ltd.
―
Options Prices
Currently, No data available
---